ReviewWorld journal of nephrology2025
Non-traditional cardiovascular risk factors after kidney transplantation.
Review in World journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Benefit and Remaining Risks of Kidney Transplantation in Older Patients: A Matched Comparison With CKD Patients.Journal of the American Geriatrics Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney transplantation remains the best treatment option for patients with end-stage kidney disease, offering superior outcomes and improved quality of life. However, as in the general population, cardiovascular disease remains the leading cause of mortality among kidney transplant recipients. While traditional cardiovascular risk factors-such as hypertension, diabetes, dyslipidemia, and tobacco use-are prevalent in this population, they are often compounded by transplant-specific and non-traditional risk factors unique to the post-transplant setting. This review aims to explore these non-traditional and transplant-related cardiovascular risk factors, including allograft dysfunction and acute rejection episodes. Moreover, we will provide an overview of the cardiovascular implications of immunosuppressive therapy, including its association with opportunistic infections such as cytomegalovirus. Finally, we will touch upon considerations for special populations of kidney transplant recipients based on our current understanding of these non-traditional cardiovascular risks with the currently available data.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.